Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multi-center, double-blind, randomized, placebo-controlled, parallel design study to evaluate the efficacy and safety of intravenous tedisamil sesquifumarate in the rapid conversion to normal sinus rhythm in female subjects with recent onset atrial fibrillation or flutter.

Trial Profile

A multi-center, double-blind, randomized, placebo-controlled, parallel design study to evaluate the efficacy and safety of intravenous tedisamil sesquifumarate in the rapid conversion to normal sinus rhythm in female subjects with recent onset atrial fibrillation or flutter.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 20 Jan 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tedisamil (Primary)
  • Indications Atrial fibrillation; Atrial flutter
  • Focus Pharmacokinetics; Registrational; Therapeutic Use
  • Most Recent Events

    • 20 Apr 2010 Additional trial locations (USA, Italy and Germany) added as reported by ClinicalTrials.gov record.
    • 06 Nov 2005 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top